{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:38:14Z","timestamp":1769585894456,"version":"3.49.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL149409"],"award-info":[{"award-number":["R01HL149409"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiovascular disease in individuals with mental health conditions such as bipolar disorder is highly prevalent and often poorly managed. Individuals with bipolar disorder face significant medication adherence barriers, especially when they are prescribed multiple medications for other health conditions including hypertension. Poor adherence puts them at a disproportionate risk for poor health outcomes. As such, there is a need for effective interventions to improve hypertension medication adherence, particularly in patients that struggle with adherence due to mental health comorbidity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This 5-year project uses a 2-stage randomized controlled trial design to evaluate a brief, practical adherence intervention delivered via interactive text messaging (iTAB-CV) along with self-monitoring of medication taking, mood, and home blood pressure (<jats:italic>N<\/jats:italic>\u2009=\u2009100) compared to self-monitoring alone (<jats:italic>N<\/jats:italic>\u2009=\u2009100). Prior to randomization, all participants will view an educational video that emphasizes the importance of medication for the treatment of hypertension and bipolar disorder. Those randomized to the texting intervention will receive daily text messages with predetermined content to address 11 salient domains as well as targeted customized messages for 2\u2009months. This group will then be re-randomized to receive either a high (gradual taper from daily to weekly texts) or low booster (weekly texts) phase for an additional 2\u2009months. All participants will be monitored for 52\u2009weeks. The primary outcomes are systolic blood pressure and adherence to antihypertensive medication as determined by a self-reported questionnaire and validated with an automated pill-monitoring device. Secondary outcomes include adherence to bipolar disorder medications, psychiatric symptoms, health status, self-efficacy for medication-taking behavior, illness beliefs, medication attitudes, and habit strength.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study specifically targets blood pressure and mental health symptom control in people with bipolar and includes implementation elements in the study design intended to inform future scale-up. Promising pilot data and a theoretical model, which views sustained medication-taking behavior in the context of habit formation, suggests that this remotely delivered intervention may help advance care for this high-risk population and is amenable to both scale up and easy adaptation for other groups with poor medication adherence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was registered at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link> (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04675593?term=NCT04675593&amp;draw=2&amp;rank=1\">NCT04675593<\/jats:ext-link>) on December 19, 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06449-9","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:04:58Z","timestamp":1656507898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-0636","authenticated-orcid":false,"given":"Jennifer B.","family":"Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Depp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1359","authenticated-orcid":false,"given":"Farren","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt C.","family":"Stange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Einstadter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Weise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Yala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Radatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Sajatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"1","key":"6449_CR1","first-page":"40","volume":"23","author":"M Weiner","year":"2011","unstructured":"Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011;23(1):40\u20137.","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"6449_CR2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.4088\/JCP.v69n0401","volume":"69","author":"WW Fleischhacker","year":"2008","unstructured":"Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, Lambert M, Leucht S, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry. 2008;69(4):514\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"6449_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"6449_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617\u201327.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"6449_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3928\/00485713-20120507-03","volume":"42","author":"M Sajatovic","year":"2012","unstructured":"Sajatovic M. Complexities of care in bipolar disorder. Psychiatr Ann. 2012;42(5):170\u20131.","journal-title":"Psychiatr Ann"},{"issue":"5","key":"6449_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","volume":"64","author":"KR Merikangas","year":"2007","unstructured":"Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543\u201352.","journal-title":"Arch Gen Psychiatry"},{"key":"6449_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jad.2017.09.011","volume":"226","author":"M Cloutier","year":"2018","unstructured":"Cloutier M, Greene M, Guerin A, Touya M, Wu E. The economic burden of bipolar I disorder in the United States in 2015. J Affect Disord. 2018;226:45\u201351.","journal-title":"J Affect Disord"},{"issue":"6","key":"6449_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4088\/JCP.v68n0614","volume":"68","author":"AB Birkenaes","year":"2007","unstructured":"Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psych. 2007;68(6):917\u201323.","journal-title":"J Clin Psych"},{"issue":"1-3","key":"6449_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jad.2009.12.024","volume":"125","author":"CM Ramsey","year":"2010","unstructured":"Ramsey CM, Leoutsakos JM, Mayer LS, Eaton WW, Lee HB. History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore epidemiologic catchment area study. J Affect Disord. 2010;125(1-3):35\u201341.","journal-title":"J Affect Disord"},{"issue":"1","key":"6449_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jad.2013.06.019","volume":"151","author":"CM Ramsey","year":"2013","unstructured":"Ramsey CM, Spira AP, Mojtabai R, Eaton WW, Roth K, Lee HB. Lifetime manic spectrum episodes and all-cause mortality: 26-year follow-up of the NIMH epidemiologic catchment area study. J Affect Disord. 2013;151(1):337\u201342.","journal-title":"J Affect Disord"},{"key":"6449_CR11","doi-asserted-by":"crossref","unstructured":"Westman J, Hallgren J, Wahlbeck K, Erlinge D, Alfredsson L, Osby U. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open. 2013;3(4).","DOI":"10.1136\/bmjopen-2012-002373"},{"issue":"2","key":"6449_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4088\/JCP.14m09300","volume":"76","author":"BI Goldstein","year":"2015","unstructured":"Goldstein BI, Schaffer A, Wang S, Blanco C. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry. 2015;76(2):163\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"6449_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1399-5618.2009.00735.x","volume":"11","author":"BI Goldstein","year":"2009","unstructured":"Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord. 2009;11(6):657\u201362.","journal-title":"Bipolar Disord"},{"issue":"3-4","key":"6449_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/10641969609088977","volume":"18","author":"FV Costa","year":"1996","unstructured":"Costa FV. Compliance with antihypertensive treatment. Clin Exp Hypertens. 1996;18(3-4):463\u201372.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"6449_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1742-1241.2007.01630.x","volume":"62","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1):76\u201387.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"6449_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/HJH.0b013e328342ca97","volume":"29","author":"G Corrao","year":"2011","unstructured":"Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610\u20138.","journal-title":"J Hypertens"},{"issue":"1","key":"6449_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2125.2009.03547.x","volume":"69","author":"S Perreault","year":"2010","unstructured":"Perreault S, Dragomir A, Roy L, White M, Blais L, Lalonde L, et al. Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol. 2010;69(1):74\u201384.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"6449_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/STROKEAHA.108.522193","volume":"40","author":"FZ Kettani","year":"2009","unstructured":"Kettani FZ, Dragomir A, Cote R, Roy L, Berard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009;40(1):213\u201320.","journal-title":"Stroke"},{"issue":"5","key":"6449_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/MLR.0b013e3181d567bd","volume":"48","author":"A Dragomir","year":"2010","unstructured":"Dragomir A, Cote R, Roy L, Blais L, Lalonde L, Berard A, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418\u201325.","journal-title":"Med Care"},{"issue":"7","key":"6449_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1176\/ps.2008.59.7.753","volume":"59","author":"M Sajatovic","year":"2008","unstructured":"Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr Serv. 2008;59(7):753\u20139.","journal-title":"Psychiatr Serv"},{"issue":"9","key":"6449_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40263-016-0368-x","volume":"30","author":"JB Levin","year":"2016","unstructured":"Levin JB, Krivenko A, Howland M, Schlachet R, Sajatovic M. Medication adherence in patients with bipolar disorder: a comprehensive review. CNS Drugs. 2016;30(9):819\u201335.","journal-title":"CNS Drugs"},{"issue":"1","key":"6449_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/bdi.12226","volume":"17","author":"CW Chang","year":"2015","unstructured":"Chang CW, Sajatovic M, Tatsuoka C. Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder. Bipolar Disord. 2015;17(1):106\u201312.","journal-title":"Bipolar Disord"},{"issue":"3","key":"6449_CR23","first-page":"5","volume":"43","author":"KK Devulapalli","year":"2010","unstructured":"Devulapalli KK, Ignacio RV, Weiden P, Cassidy KA, Williams TD, Safavi R, et al. Why do persons with bipolar disorder stop their medication? Psychopharmacol Bull. 2010;43(3):5\u201314.","journal-title":"Psychopharmacol Bull"},{"issue":"19","key":"6449_CR24","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127\u2013248.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"6449_CR25","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright","year":"2015","unstructured":"Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"6449_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/hup.908","volume":"23","author":"RJ Baldessarini","year":"2008","unstructured":"Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 2008;23(2):95\u2013105.","journal-title":"Hum Psychopharmacol"},{"issue":"Suppl 4","key":"6449_CR27","first-page":"1","volume":"70","author":"DI Velligan","year":"2009","unstructured":"Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(Suppl 4):1\u201346 quiz 7-8.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"6449_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/NMD.0000000000000544","volume":"205","author":"JB Levin","year":"2017","unstructured":"Levin JB, Krivenko A, Bukach A, Tatsuoka C, Cassidy KA, Sajatovic M. A reexamination of nonpsychiatric medication adherence in individuals with bipolar disorder and medical comorbidities. J Nerv Ment Dis. 2017;205(3):182\u20137.","journal-title":"J Nerv Ment Dis"},{"issue":"2","key":"6449_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/HYPERTENSIONAHA.112.192096","volume":"60","author":"SL Daugherty","year":"2012","unstructured":"Daugherty SL, Powers JD, Magid DJ, Masoudi FA, Margolis KL, O\u2019Connor PJ, et al. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Hypertension. 2012;60(2):303\u20139.","journal-title":"Hypertension."},{"key":"6449_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40885-020-00151-1","volume":"26","author":"FM Algabbani","year":"2020","unstructured":"Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clin Hypertens. 2020;26:18.","journal-title":"Clin Hypertens"},{"issue":"4","key":"6449_CR31","first-page":"1","volume":"208","author":"M Viswanathan","year":"2012","unstructured":"Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock S, Wines RC, et al. Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness). Evid Rep\/Technol Assessment. 2012;208(4):1\u2013685.","journal-title":"Evid Rep\/Technol Assessment"},{"key":"6449_CR32","first-page":"CD000011","volume":"11","author":"R Nieuwlaat","year":"2014","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"6449_CR33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/arclin\/acq061","volume":"25","author":"E Lee","year":"2010","unstructured":"Lee E, Xiang YT, Man D, Au RW, Shum D, Tang WK, et al. Prospective memory deficits in patients with bipolar disorder: a preliminary study. Arch Clin Neuropsychol. 2010;25(7):640\u20137.","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"6449_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10865-011-9341-9","volume":"35","author":"JB Zogg","year":"2012","unstructured":"Zogg JB, Woods SP, Sauceda JA, Wiebe JS, Simoni JM. The role of prospective memory in medication adherence: a review of an emerging literature. J Behav Med. 2012;35(1):47\u201362.","journal-title":"J Behav Med"},{"issue":"3","key":"6449_CR35","first-page":"e85","volume":"19","author":"HR Bogner","year":"2013","unstructured":"Bogner HR, de Vries HF, O\u2019Donnell AJ, Morales KH. Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes. Am J Manag Care. 2013;19(3):e85\u201392.","journal-title":"Am J Manag Care"},{"issue":"3","key":"6449_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.comppsych.2010.07.002","volume":"52","author":"M Sajatovic","year":"2011","unstructured":"Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry. 2011;52(3):280\u20137.","journal-title":"Compr Psychiatry"},{"issue":"5","key":"6449_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000228248","volume":"78","author":"DC Mohr","year":"2009","unstructured":"Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, et al. The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom. 2009;78(5):275\u201384.","journal-title":"Psychother Psychosom"},{"issue":"9","key":"6449_CR38","doi-asserted-by":"publisher","first-page":"e1002389","DOI":"10.1371\/journal.pmed.1002389","volume":"14","author":"KL Tucker","year":"2017","unstructured":"Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389.","journal-title":"PLoS Med"},{"key":"6449_CR39","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ."},{"key":"6449_CR40","unstructured":"British Hypertension Society. Home blood pressure monitoring protocol. 2017. https:\/\/bihsoc.org\/wp-content\/uploads\/2017\/09\/Protocol.pdf. Accessed 19 Dec 2020."},{"key":"6449_CR41","unstructured":"Omron Healthcare. Clinical validation. 2021. https:\/\/omronhealthcare.com\/service-and-support\/clinical-validation\/. Accessed 19 Dec 2020."},{"key":"6449_CR42","doi-asserted-by":"crossref","unstructured":"Levin JB, Sams J, Tatsuoka C, Cassidy KA, Sajatovic M. Use of automated medication adherence monitoring in bipolar disorder research: pitfalls, pragmatics, and possibilities. Therapeutic advances. Psychopharmacology. 2015;2045125314566807.","DOI":"10.1177\/2045125314566807"},{"key":"6449_CR43","unstructured":"NIH NIMH. Bipolar disorder. 2015. [https:\/\/www.nimh.nih.gov\/health\/publications\/bipolar-disorder\/index.shtml. Accessed 19 Dec 2020."},{"issue":"1","key":"6449_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.hrtlng.2010.02.003","volume":"40","author":"C Bolman","year":"2011","unstructured":"Bolman C, Arwert TG, Vollink T. Adherence to prophylactic asthma medication: habit strength and cognitions. Heart Lung. 2011;40(1):63\u201375.","journal-title":"Heart Lung"},{"issue":"1","key":"6449_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5430\/ijh.v4n1p25","volume":"4","author":"C Blixen","year":"2018","unstructured":"Blixen C, Sajatovic M, Moore DJ, Depp C, Cushman C, Cage J, et al. Patient participation in the development of a customized m-health intervention to improve medication adherence in poorly adherent individuals with bipolar disorder (BD) and hypertension (HTN). Int J Healthcare. 2018;4(1):25\u201335.","journal-title":"Int J Healthcare"},{"issue":"5","key":"6449_CR46","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1037\/0022-006X.71.5.862","volume":"71","author":"PC Amrhein","year":"2003","unstructured":"Amrhein PC, Miller WR, Yahne CE, Palmer M, Fulcher L. Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psychol. 2003;71(5):862\u201378.","journal-title":"J Consult Clin Psychol"},{"key":"6449_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/epirev\/mxq004","volume":"32","author":"H Cole-Lewis","year":"2010","unstructured":"Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32:56\u201369.","journal-title":"Epidemiol Rev"},{"issue":"3","key":"6449_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10461-014-0971-0","volume":"19","author":"D Moore","year":"2015","unstructured":"Moore D, Poquette A, Casaletto K, Gouaux B, Montoya J, Posada C, et al. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behavior. 2015;19(3):459\u201371.","journal-title":"AIDS Behavior"},{"issue":"10","key":"6449_CR49","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00431-006-0156-6","volume":"165","author":"B Rami","year":"2006","unstructured":"Rami B, Popow C, Horn W, Waldhoer T, Schober E. Telemedical support to improve glycemic control in adolescents with type 1 diabetes mellitus. Eur J Pediatr. 2006;165(10):701\u20135.","journal-title":"Eur J Pediatr"},{"key":"6449_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12888-015-0456-3","volume":"15","author":"SJ Richmond","year":"2015","unstructured":"Richmond SJ, Keding A, Hover M, Gabe R, Cross B, Torgerson D, et al. Feasibility, acceptability and validity of SMS text messaging for measuring change in depression during a randomised controlled trial. BMC Psychiatry. 2015;15:68.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"6449_CR51","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1161\/CIR.0000000000000803","volume":"142","author":"D Shimbo","year":"2020","unstructured":"Shimbo D, Artinian NT, Basile JN, Krakoff LR, Margolis KL, Rakotz MK, et al. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42\u201363.","journal-title":"Circulation."},{"issue":"5","key":"6449_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4088\/JCP.v63n0502","volume":"63","author":"J Scott","year":"2002","unstructured":"Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;63(5):384\u201390.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"6449_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1034\/j.1600-0447.2000.90061.x","volume":"101","author":"J Adams","year":"2000","unstructured":"Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101(2):119\u201324.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"6449_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/2045125314566807","volume":"5","author":"JB Levin","year":"2015","unstructured":"Levin JB, Sams J, Tatsuoka C, Cassidy KA, Sajatovic M. Use of automated medication adherence monitoring in bipolar disorder research: pitfalls, pragmatics, and possibilities. Ther Adv Psychopharmacol. 2015;5(2):76\u201387.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"Suppl 20","key":"6449_CR55","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"6449_CR56","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/01.mlr.0000163658.65008.ec","volume":"43","author":"S Chaudhry","year":"2005","unstructured":"Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson comorbidity index for predicting mortality. Med Care. 2005;43(6):607\u201315.","journal-title":"Med Care"},{"issue":"11","key":"6449_CR57","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/MLR.0b013e3180616c1b","volume":"45","author":"AM Arozullah","year":"2007","unstructured":"Arozullah AM, Yarnold PR, Bennett CL, Soltysik RC, Wolf MS, Ferreira RM, et al. Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007;45(11):1026\u201333.","journal-title":"Med Care"},{"issue":"11","key":"6449_CR58","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1176\/appi.ajp.159.11.1927","volume":"159","author":"J Scott","year":"2002","unstructured":"Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry. 2002;159(11):1927\u20139.","journal-title":"Am J Psychiatry"},{"key":"6449_CR59","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JA Overall","year":"1962","unstructured":"Overall JA, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799\u2013812.","journal-title":"Psychol Rep"},{"issue":"7","key":"6449_CR60","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L","volume":"15","author":"AF Leentjens","year":"2000","unstructured":"Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson\u2019s disease. Int J Geriatr Psychiatry. 2000;15(7):644\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"6449_CR61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10865-008-9170-7","volume":"31","author":"S Fernandez","year":"2008","unstructured":"Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31(6):453\u201362.","journal-title":"J Behav Med"},{"issue":"6","key":"6449_CR62","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/j.1559-1816.2003.tb01951.x","volume":"33","author":"B Verplanken","year":"2003","unstructured":"Verplanken B, Orbell S. Reflections on past behavior: a self-report index of habit strength. J Appl Soc Psychol. 2003;33(6):1313\u201330.","journal-title":"J Appl Soc Psychol"},{"key":"6449_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1\u201324.","journal-title":"Psychol Health"},{"issue":"4","key":"6449_CR64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0165-0327(91)90067-3","volume":"22","author":"NS Harvey","year":"1991","unstructured":"Harvey NS. The development and descriptive use of the lithium attitudes questionnaire. J Affect Disord. 1991;22(4):211\u20139.","journal-title":"J Affect Disord"},{"issue":"2","key":"6449_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"6449_CR66","volume-title":"Stata statistical software: release 13","author":"Stata Corp","year":"2013","unstructured":"Stata Corp. Stata statistical software: release 13. College Station: StataCorp LP; 2013."},{"issue":"8476","key":"6449_CR67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307\u201310.","journal-title":"Lancet."},{"key":"6449_CR68","volume-title":"Introduction to statistical mediation analysis","author":"D MacKinnon","year":"2008","unstructured":"MacKinnon D. Introduction to statistical mediation analysis. New York: Routledge; 2008."},{"issue":"3","key":"6449_CR69","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3758\/BRM.40.3.879","volume":"40","author":"KJ Preacher","year":"2008","unstructured":"Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879\u201391.","journal-title":"Behav Res Methods"},{"issue":"25","key":"6449_CR70","first-page":"51","volume":"1","author":"K Imai","year":"2010","unstructured":"Imai K, Keele L, Yamamoto T. Identification, inference and sensitivity analysis for causal mediation effects. Stat Sci. 2010;1(25):51\u201371.","journal-title":"Stat Sci"},{"issue":"24","key":"6449_CR71","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1002\/sim.5830","volume":"32","author":"W Wang","year":"2013","unstructured":"Wang W, Nelson S, Albert JM. Estimation of causal mediation effects for a dichotomous outcome in multiple-mediator models using the mediation formula. Stat Med. 2013;32(24):4211\u201328.","journal-title":"Stat Med"},{"key":"6449_CR72","unstructured":"RMASS. Statistical power computations for 3-level mixed-effects regression models [computer program]. University of Illinois at Chicago."},{"issue":"9","key":"6449_CR73","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1176\/appi.ps.201600377","volume":"68","author":"M Sajatovic","year":"2017","unstructured":"Sajatovic M, Gunzler DD, Kanuch SW, Cassidy KA, Tatsuoka C, McCormick R, et al. A 60-week prospective RCT of a self-management intervention for individuals with serious mental illness and diabetes mellitus. Psychiatr Serv. 2017;68(9):883\u201390.","journal-title":"Psychiatr Serv"},{"issue":"10","key":"6449_CR74","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ajh.2008.240","volume":"21","author":"G Ogedegbe","year":"2008","unstructured":"Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, Richardson T, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21(10):1137\u201343.","journal-title":"Am J Hypertens"},{"key":"6449_CR75","doi-asserted-by":"crossref","unstructured":"Wong GW, Wright JM. Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension. Cochrane Database Syst Rev. 2014;(2):CD007452.","DOI":"10.1002\/14651858.CD007452.pub2"},{"key":"6449_CR76","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin DB. Inference and missing data. Biometrika. 1976;63:581\u201392.","journal-title":"Biometrika."},{"issue":"1","key":"6449_CR77","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2307\/2534023","volume":"54","author":"TR Ten Have","year":"1998","unstructured":"Ten Have TR, Kunselman AR, Pulkstenis EP, Landis JR. Mixed effects logistic regression models for longitudinal binary response data with informative drop-out. Biometrics. 1998;54(1):367\u201383.","journal-title":"Biometrics."},{"key":"6449_CR78","unstructured":"Chen F, editor. Missing no more: using the MCMC procedure to model missing data. SAS Global Forum; 2013."},{"issue":"3","key":"6449_CR79","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/tmj.2008.0099","volume":"15","author":"S Krishna","year":"2009","unstructured":"Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009;15(3):231\u201340.","journal-title":"Telemed J E Health"},{"key":"6449_CR80","unstructured":"Blumberg S, Luke J. Wireless substitution: early release of estimates from the National Health Interview Survey, July-December 2013. InNCH Stats. 2014."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06449-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06449-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06449-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T14:05:10Z","timestamp":1656511510000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06449-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6449"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06449-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An operations manager will submit all study procedures and protocol modifications to the internal IRB at University Hospitals Cleveland Medical Center (UHCMC, IRB00000684 and\/or IRB00001691) for review and approval before conducting new procedures on a participant. Participants will be informed of any modifications that could affect their decision to participate. Informed consent will be obtained for all SAB members and RCT participants, and all work will be conducted consistent with IRB approval at UHCMC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.S. has research grants from Otsuka, Alkermes, Nuromate, the International Society of Bipolar Disorders (ISBD), National Institute of Health (NIH), and the Centers for Disease Control and Prevention (CDC). M.S. is a consultant to Alkermes, Otsuka, Janssen, Neurocrine, Bracket, Health Analytics, and Frontline Medical Communications and has received publication royalties from Springer Press, Johns Hopkins University Press, Oxford Press, UpToDate. The remaining authors declare that they have no competing interests. J.B.L. has research grants from National Institute of Health (NIH). The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"539"}}